Fatty liver disease (MASLD/MASH): open trials in Switzerland

12 open trials have a site in Switzerland. Registry data; only the trial team decides who can take part.

NCT06215716
A Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Fibrosis
Trial Treatment · Phase 3 · Akero Therapeutics, Inc
Bern · Olten · Sankt Gallen
Registry updated 2026-11-06
NCT06632444
LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis
Trial Treatment · Phase 3 · Boehringer Ingelheim
Fondazione Epatocentro Ticino, Arzo · University Hospital Bern, Bern · Hôpitaux Universitaires de Genève (HUG), Geneva · University Hospital Zurich, Zurich
Registry updated 2026-10-28
NCT06632457
LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis
Trial Treatment · Phase 3 · Boehringer Ingelheim
Fondazione Epatocentro Ticino, Arzo · Hôpitaux Universitaires de Genève (HUG), Geneva · University Hospital Zurich, Zurich
Registry updated 2026-10-28
NCT06528314
A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
Trial Treatment · Phase 3 · Akero Therapeutics, Inc
Bern · Lugano · Olten · Sankt Gallen · Zurich
Registry updated 2026-10-13
NCT07165028
A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)
Trial Treatment · Phase 3 · Eli Lilly and Company
University Hospital Basel, Basel · Kantonsspital Olten, Olten
Registry updated 2026-10-08
NCT06546384
GLP-1 RA on Alcohol Consumption, Metabolism and Liver Parameters in Patients With Obesity and Fatty Liver Disease
Trial Treatment · Insel Gruppe AG, University Hospital Bern
University Hospital Bern, Bern
Registry updated 2026-08-19
NCT06374875
Fibrosis Lessens After Metabolic Surgery
Trial Treatment · Phase 4 · The Cleveland Clinic
Clarunis Universitäres, Basel · Hôpitaux universitaires de Genève, Geneva
Registry updated 2026-07-31
NCT07051863
Prospective Cohort and Biobank of Patients With Nonalcoholic Fatty Liver Disease
Research · Fondazione Epatocentro Ticino
Fondazione Epatocentro Ticino, Lugano
Registry updated 2026-07-21
NCT07280143
The Development of MASLD Among Survivors of Breast or Colorectal Cancer
Research · University of Bern
Department of Clinical Research, University of Bern, Bern
Registry updated 2025-12-12
NCT05385237
Identification of Hepatic Fibrosis Using 4D-MRI
Trial Treatment · University Hospital, Basel, Switzerland
University Hospital Basel, Basel · Kantonsspital Baselland (KSL), Liestal
Registry updated 2025-03-18
NCT04442334
The European NAFLD Registry
Research · Newcastle University
Inselspital, University Hospital, Bern
Registry updated 2023-01-06
NCT00575133
Prospective Cohort Study in Patients With NAFLD
Research · University of Zurich
University Hospital Zurich, Endocrinology and Diabetology, Zurich
Registry updated 2012-02-24

All Fatty liver disease (MASLD/MASH) trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error